Cargando…

Grip strength is inversely associated with DNA methylation age acceleration

BACKGROUND: There is a large body of evidence linking muscular weakness, as determined by low grip strength, to a host of negative ageing‐related health outcomes. Given these links, grip strength has been labelled a ‘biomarker of aging’; and yet, the pathways connecting grip strength to negative hea...

Descripción completa

Detalles Bibliográficos
Autores principales: Peterson, Mark D., Collins, Stacey, Meier, Helen C.S., Brahmsteadt, Alexander, Faul, Jessica D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9891916/
https://www.ncbi.nlm.nih.gov/pubmed/36353822
http://dx.doi.org/10.1002/jcsm.13110
_version_ 1784881235370180608
author Peterson, Mark D.
Collins, Stacey
Meier, Helen C.S.
Brahmsteadt, Alexander
Faul, Jessica D.
author_facet Peterson, Mark D.
Collins, Stacey
Meier, Helen C.S.
Brahmsteadt, Alexander
Faul, Jessica D.
author_sort Peterson, Mark D.
collection PubMed
description BACKGROUND: There is a large body of evidence linking muscular weakness, as determined by low grip strength, to a host of negative ageing‐related health outcomes. Given these links, grip strength has been labelled a ‘biomarker of aging’; and yet, the pathways connecting grip strength to negative health consequences are unclear. The objective of this study was to determine whether grip strength was associated with measures of DNA methylation (DNAm) age acceleration. METHODS: Middle age and older adults from the 2006 to 2008 waves of the Health and Retirement Study with 8–10 years of follow‐up were included. Cross‐sectional and longitudinal regression modelling was performed to examine the association between normalized grip strength (NGS) and three measures of DNAm age acceleration, adjusting for cell composition, sociodemographic variables and smoking. Longitudinal modelling was also completed to examine the association between change in absolute grip strength and DNAm age acceleration. The three DNAm clocks used for estimating age acceleration include the established DunedinPoAm, PhenoAge and GrimAge clocks. RESULTS: There was a robust and independent cross‐sectional association between NGS and DNAm age acceleration for men using the DunedinPoAm (β: −0.36; P < 0.001), PhenoAge (β: −8.27; P = 0.01) and GrimAge (β: −4.56; P = 0.01) clocks and for women using the DunedinPoAm (β: −0.36; P < 0.001) and GrimAge (β: −4.46; P = 0.01) clocks. There was also an independent longitudinal association between baseline NGS and DNAm age acceleration for men (β: −0.26; P < 0.001) and women (β: −0.36; P < 0.001) using the DunedinPoAm clock and for women only using the PhenoAge (β: −8.20; P < 0.001) and GrimAge (β: −5.91; P < 0.001) clocks. Longitudinal modelling revealed a robust association between change in grip strength from wave 1 to wave 3 was independently associated with PhenoAgeAA (β: −0.13; 95% CI: −0.23, −0.03) and GrimAgeAA (β: −0.07; 95% CI: −0.14, −0.01) in men only (both P < 0.05). CONCLUSIONS: Our findings provide some initial evidence of age acceleration among men and women with lower NGS and loss of strength over time. Future research is needed to understand the extent to which DNAm age mediates the association between grip strength and chronic disease, disability and mortality.
format Online
Article
Text
id pubmed-9891916
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-98919162023-02-02 Grip strength is inversely associated with DNA methylation age acceleration Peterson, Mark D. Collins, Stacey Meier, Helen C.S. Brahmsteadt, Alexander Faul, Jessica D. J Cachexia Sarcopenia Muscle Original Articles BACKGROUND: There is a large body of evidence linking muscular weakness, as determined by low grip strength, to a host of negative ageing‐related health outcomes. Given these links, grip strength has been labelled a ‘biomarker of aging’; and yet, the pathways connecting grip strength to negative health consequences are unclear. The objective of this study was to determine whether grip strength was associated with measures of DNA methylation (DNAm) age acceleration. METHODS: Middle age and older adults from the 2006 to 2008 waves of the Health and Retirement Study with 8–10 years of follow‐up were included. Cross‐sectional and longitudinal regression modelling was performed to examine the association between normalized grip strength (NGS) and three measures of DNAm age acceleration, adjusting for cell composition, sociodemographic variables and smoking. Longitudinal modelling was also completed to examine the association between change in absolute grip strength and DNAm age acceleration. The three DNAm clocks used for estimating age acceleration include the established DunedinPoAm, PhenoAge and GrimAge clocks. RESULTS: There was a robust and independent cross‐sectional association between NGS and DNAm age acceleration for men using the DunedinPoAm (β: −0.36; P < 0.001), PhenoAge (β: −8.27; P = 0.01) and GrimAge (β: −4.56; P = 0.01) clocks and for women using the DunedinPoAm (β: −0.36; P < 0.001) and GrimAge (β: −4.46; P = 0.01) clocks. There was also an independent longitudinal association between baseline NGS and DNAm age acceleration for men (β: −0.26; P < 0.001) and women (β: −0.36; P < 0.001) using the DunedinPoAm clock and for women only using the PhenoAge (β: −8.20; P < 0.001) and GrimAge (β: −5.91; P < 0.001) clocks. Longitudinal modelling revealed a robust association between change in grip strength from wave 1 to wave 3 was independently associated with PhenoAgeAA (β: −0.13; 95% CI: −0.23, −0.03) and GrimAgeAA (β: −0.07; 95% CI: −0.14, −0.01) in men only (both P < 0.05). CONCLUSIONS: Our findings provide some initial evidence of age acceleration among men and women with lower NGS and loss of strength over time. Future research is needed to understand the extent to which DNAm age mediates the association between grip strength and chronic disease, disability and mortality. John Wiley and Sons Inc. 2022-11-09 /pmc/articles/PMC9891916/ /pubmed/36353822 http://dx.doi.org/10.1002/jcsm.13110 Text en © 2022 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of Society on Sarcopenia, Cachexia and Wasting Disorders. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Articles
Peterson, Mark D.
Collins, Stacey
Meier, Helen C.S.
Brahmsteadt, Alexander
Faul, Jessica D.
Grip strength is inversely associated with DNA methylation age acceleration
title Grip strength is inversely associated with DNA methylation age acceleration
title_full Grip strength is inversely associated with DNA methylation age acceleration
title_fullStr Grip strength is inversely associated with DNA methylation age acceleration
title_full_unstemmed Grip strength is inversely associated with DNA methylation age acceleration
title_short Grip strength is inversely associated with DNA methylation age acceleration
title_sort grip strength is inversely associated with dna methylation age acceleration
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9891916/
https://www.ncbi.nlm.nih.gov/pubmed/36353822
http://dx.doi.org/10.1002/jcsm.13110
work_keys_str_mv AT petersonmarkd gripstrengthisinverselyassociatedwithdnamethylationageacceleration
AT collinsstacey gripstrengthisinverselyassociatedwithdnamethylationageacceleration
AT meierhelencs gripstrengthisinverselyassociatedwithdnamethylationageacceleration
AT brahmsteadtalexander gripstrengthisinverselyassociatedwithdnamethylationageacceleration
AT fauljessicad gripstrengthisinverselyassociatedwithdnamethylationageacceleration